Physician profile
Ruth A Johnson
NPI 1285619072
$596.97
in general payments reported to CMS, 2019-2025
9 companies · $75.26 in 2025
The $75.26 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $80.82 · 2022: $104 · 2024: $88.76 · 2025: $75.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.03 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $193.12 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.62 | 2019-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $104.16 | 2022 | |
| Harmony Biosciences LLC | $48.77 | 2024 | |
| Pfizer INC. | $39.99 | 2024 | |
| Azurity Pharmaceuticals, INC. | $21.36 | 2025 | Azmiro |
| Bausch Health US, LLC | $20.64 | 2025 | Aplenzin, Wellbutrin |
| Ibsa Pharma INC. | $18.25 | 2019 | |
| Endo Pharmaceuticals INC. | $18.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.